A phase II study of palbociclib combined with retifanlimab in patients with advanced dedifferentiated liposarcoma Meeting Abstract

  

Authors:	D'Angelo, S. P.; Rosenbaum, E.; Gularte Mérida, R.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; Chan, J. E.; Cho, J.; Biniakewitz, M.; Cho, G.; Erinjeri, J. P.; Lefkowitz, R. A.; Antonescu, C. R.; Qin, L. X.; Singer, S.; Tap, W. D.
Abstract Title:	A phase II study of palbociclib combined with retifanlimab in patients with advanced dedifferentiated liposarcoma
Meeting Title:	2023 ASCO Annual Meeting
Journal Title:	Journal of Clinical Oncology
Volume:	41
Issue:	16 Suppl.
Meeting Dates:	2023 Jun 2-6
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2023-06-01
Language:	English
DOI:	10.1200/JCO.2023.41.16_suppl.TPS11590
PROVIDER:	EBSCOhost
PROVIDER:	cinahl
DOI/URL:	https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=cin20&AN=164018130&authtype=sso&custid=s2915669&site=ehost-live&scope=site&custid=s2915669
Notes:	Meeting Abstract: TPS11590 -- Meeting was also available virtually -- Source: Cinahl

https://synapse.mskcc.org/synapse/works/has_related_data_chk/209709